跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 38,450 条关于
“Rod derived Cone Viability Factor”
全部
38,450
临床试验
28,648
药物
2,658
机构
160
资讯
6,984
7个月前
SparingVision Completes Dosing in Phase I/II Trial for Gene-Agnostic Retinitis Pigmentosa Therapy SPVN06
去年
FDA Grants Fast Track Status to BlueRock's Novel Cell Therapy for Inherited Retinal Diseases
2年前
FDA Grants Orphan Drug Designation to Skyline Therapeutics' SKG1108 for Retinitis Pigmentosa
去年
Variant Secures EMA Endorsement for VAR002 Gene Therapy Targeting Inherited Retinal Dystrophies
去年
CIRM Awards $4.7 Million to Advance AAV Gene Therapy for Blue Cone Monochromacy
2年前
BlueRock Therapeutics' OpCT-001 Receives FDA Clearance for Phase I/IIa Trial in Primary Photoreceptor Diseases
5年前
Sangamo Therapeutics Charts Pragmatic Course in Gene Editing Evolution, Balancing Innovation with Viability
4个月前
Factor Bioscience Advances IL-12-Engineered iMacrophage Therapy for Solid Tumors with Promising Ovarian Cancer Data
去年
jCyte Initiates Phase 2 Trial of Famzeretcel Cell Therapy for Retinitis Pigmentosa
去年
Ocugen's OCU410ST Receives Orphan Drug Designation from EMA for ABCA4 Retinopathies
第 1 页，共 699 页
上一页
下一页
